Walters J R, Banks L M, Butcher G P, Fowler C R
Department of Medicine, Hammersmith Hospital, Royal Postgraduate Medical School, London.
Gut. 1995 Aug;37(2):220-4. doi: 10.1136/gut.37.2.220.
Patients with coeliac disease may present with calcium malabsorption but it is unclear whether this results in longterm impairment of bone mineralisation. Dual energy x ray absorptiometry (DXA) was used to study bone mineral density in 34 asymptomatic coeliac disease patients, treated with a gluten free diet for at least two years, and also in 10 newly diagnosed or untreated patients. As expected, untreated patients had low bone mineral density in all regions. In the 29 treated female coeliac disease patients, overall mean values for age adjusted bone mineral density expressed as Z scores were normal although there were many patients with low values, particularly of the lumbar spine and total body. Scores in the postmenopausal patients were significantly worse than in the premenopausal patients and low mean Z scores were found in the five treated male patients. The subjects who had reduced bone mineral density could not be predicted clinically but, despite being asymptomatic, were more likely to have subtotal or partial villous atrophy on small intestinal biopsy (p < 0.0275). In conclusion, although many treated coeliac disease patients have normal bone mineral density, suboptimally treated and newly diagnosed or untreated patients have osteopenia. To reduce the risk of osteoporotic fractures, it is recommended that bone mineral density be measured in all treated coeliac disease patients and those with osteopenia have a repeat intestinal biopsy to assess disease activity.
乳糜泻患者可能存在钙吸收不良,但尚不清楚这是否会导致骨矿化的长期损害。采用双能X线吸收法(DXA)对34例无症状乳糜泻患者进行骨密度研究,这些患者接受无麸质饮食治疗至少两年,同时也对10例新诊断或未治疗的患者进行了研究。正如预期的那样,未治疗的患者在所有部位的骨密度都较低。在29例接受治疗的女性乳糜泻患者中,以Z值表示的年龄校正骨密度总体平均值正常,尽管有许多患者的值较低,尤其是腰椎和全身。绝经后患者的得分明显低于绝经前患者,在5例接受治疗的男性患者中发现平均Z值较低。骨密度降低的受试者无法通过临床预测,但尽管无症状,小肠活检时更有可能出现全层或部分绒毛萎缩(p<0.0275)。总之,尽管许多接受治疗的乳糜泻患者骨密度正常,但治疗不充分以及新诊断或未治疗的患者存在骨质减少。为降低骨质疏松性骨折的风险,建议对所有接受治疗的乳糜泻患者进行骨密度测量,对骨质减少的患者进行重复小肠活检以评估疾病活动度。